{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:21:38Z","timestamp":1707524498250},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,3]]},"DOI":"10.7759\/cureus.23789","type":"journal-article","created":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T18:41:56Z","timestamp":1649011316000},"source":"Crossref","is-referenced-by-count":2,"title":["Dimethyl Fumarate-Induced Takotsubo Cardiomyopathy in a Patient With Relapsing-Remitting Multiple Sclerosis"],"prefix":"10.7759","author":[{"given":"Bahadar S","family":"Srichawla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1177\/0897190018824821","article-title":"Adherence to disease-modifying therapies at a multiple sclerosis clinic: the role of the specialty pharmacist","volume":"33","author":"Banks AM","year":"2020","unstructured":"Banks AM, Peter ME, Holder GM, et al.. Adherence to disease-modifying therapies at a multiple sclerosis clinic: the role of the specialty pharmacist. J Pharm Pract. 2020, 33:605-11. 10.1177\/0897190018824821","journal-title":"J Pharm Pract"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-019-01229-3","article-title":"Dimethyl fumarate: a review in relapsing-remitting MS","volume":"79","author":"Blair HA","year":"2019","unstructured":"Blair HA. Dimethyl fumarate: a review in relapsing-remitting MS. Drugs. 2019, 79:1965-76. 10.1007\/s40265-019-01229-3","journal-title":"Drugs"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7224\/1537-2073.2014-069","article-title":"Clinical significance of gastrointestinal and flushing events in patients with multiple sclerosis treated with delayed-release dimethyl fumarate","volume":"17","author":"Phillips JT","year":"2015","unstructured":"Phillips JT, Selmaj K, Gold R, et al.. Clinical significance of gastrointestinal and flushing events in patients with multiple sclerosis treated with delayed-release dimethyl fumarate. Int J MS Care. 2015, 17:236-43. 10.7224\/1537-2073.2014-069","journal-title":"Int J MS Care"},{"key":"ref4","article-title":"Takotsubo cardiomyopathy: a brief review","volume":"13","author":"Amin HZ","year":"2020","unstructured":"Amin HZ, Amin LZ, Pradipta A. Takotsubo cardiomyopathy: a brief review. J Med Life. 2020, 13:3-7.","journal-title":"J Med Life"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.11477\/mf.1416201784","article-title":"Relapsing-remitting multiple sclerosis. (Article in Japanese)","volume":"73","author":"Niino M","year":"2021","unstructured":"Niino M, Miyazaki Y. Relapsing-remitting multiple sclerosis. (Article in Japanese). Brain Nerve. 2021, 73:442-9. 10.11477\/mf.1416201784","journal-title":"Brain Nerve"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurol.2018.03.012","article-title":"First-line therapy in relapsing remitting multiple sclerosis","volume":"174","author":"Biotti D","year":"2018","unstructured":"Biotti D, Ciron J. First-line therapy in relapsing remitting multiple sclerosis. Rev Neurol (Paris). 2018, 174:419-28. 10.1016\/j.neurol.2018.03.012","journal-title":"Rev Neurol (Paris)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0000000000000746","article-title":"Iatrogenic or anaphylaxis-triggered takotsubo syndrome?","volume":"25","author":"Madias JE","year":"2018","unstructured":"Madias JE. Iatrogenic or anaphylaxis-triggered takotsubo syndrome?. Am J Ther. 2018, 25:e735. 10.1097\/MJT.0000000000000746","journal-title":"Am J Ther"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2016.11.266","article-title":"Takotsubo cardiomyopathy associated with epinephrine use: a systematic review and meta-analysis","volume":"229","author":"Nazir S","year":"2017","unstructured":"Nazir S, Lohani S, Tachamo N, Ghimire S, Poudel DR, Donato A. Takotsubo cardiomyopathy associated with epinephrine use: a systematic review and meta-analysis. Int J Cardiol. 2017, 229:67-70. 10.1016\/j.ijcard.2016.11.266","journal-title":"Int J Cardiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2015.09.038","article-title":"Evaluation of myocardial injury through serum troponin I and echocardiography in anaphylaxis","volume":"34","author":"Cha YS","year":"2016","unstructured":"Cha YS, Kim H, Bang MH, et al.. Evaluation of myocardial injury through serum troponin I and echocardiography in anaphylaxis. Am J Emerg Med. 2016, 34:140-4. 10.1016\/j.ajem.2015.09.038","journal-title":"Am J Emerg Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-018-1185-0","article-title":"A comprehensive review on the treatment approaches of multiple sclerosis: currently and in the future","volume":"68","author":"Gholamzad M","year":"2019","unstructured":"Gholamzad M, Ebtekar M, Ardestani MS, Azimi M, Mahmodi Z, Mousavi MJ, Aslani S. A comprehensive review on the treatment approaches of multiple sclerosis: currently and in the future. Inflamm Res. 2019, 68:25-38. 10.1007\/s00011-018-1185-0","journal-title":"Inflamm Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102137","article-title":"Cryptococcal meningitis in a patient with multiple sclerosis on dimethyl fumarate treatment: a case report","volume":"42","author":"Workel HH","year":"2020","unstructured":"Workel HH, Wolfhagen MJ, Bouwhuis JW, Kloosterziel ME. Cryptococcal meningitis in a patient with multiple sclerosis on dimethyl fumarate treatment: a case report. Mult Scler Relat Disord. 2020, 42:102137. 10.1016\/j.msard.2020.102137","journal-title":"Mult Scler Relat Disord"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26328","article-title":"Immunological predictors of dimethyl fumarate-induced lymphopenia [PREPRINT]","author":"Diebold M","year":"2022","unstructured":"Diebold M, Galli E, Kopf A, et al.. Immunological predictors of dimethyl fumarate-induced lymphopenia [PREPRINT]. Ann Neurol. 2022, 10.1002\/ana.26328","journal-title":"Ann Neurol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan4665","article-title":"Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity","volume":"360","author":"Kornberg MD","year":"2018","unstructured":"Kornberg MD, Bhargava P, Kim PM, et al.. Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity. Science. 2018, 360:449-53. 10.1126\/science.aan4665","journal-title":"Science"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.hfc.2012.12.004","article-title":"Drug-induced takotsubo cardiomyopathy","volume":"9","author":"Izumi Y","year":"2013","unstructured":"Izumi Y. Drug-induced takotsubo cardiomyopathy. Heart Fail Clin. 2013, 9:225-31, ix-x. 10.1016\/j.hfc.2012.12.004","journal-title":"Heart Fail Clin"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0120254","article-title":"Dimethyl fumarate and monoethyl fumarate exhibit differential effects on KEAP1, NRF2 activation, and glutathione depletion in vitro","volume":"10","author":"Brennan MS","year":"2015","unstructured":"Brennan MS, Matos MF, Li B, et al.. Dimethyl fumarate and monoethyl fumarate exhibit differential effects on KEAP1, NRF2 activation, and glutathione depletion in vitro. PLoS One. 2015, 10:e0120254. 10.1371\/journal.pone.0120254","journal-title":"PLoS One"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-021-10779-0","article-title":"COVID-19-related severe MS exacerbation with life-threatening takotsubo cardiomyopathy in a previously stable patient and interference of MS therapy with long-term immunity against SARS-CoV-2","volume":"269","author":"Wildemann B","year":"2022","unstructured":"Wildemann B, Jarius S, Lehmann LH, et al.. COVID-19-related severe MS exacerbation with life-threatening takotsubo cardiomyopathy in a previously stable patient and interference of MS therapy with long-term immunity against SARS-CoV-2. J Neurol. 2022, 269:1138-41. 10.1007\/s00415-021-10779-0","journal-title":"J Neurol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1177\/1352458516638557","article-title":"An uncommon first manifestation of multiple sclerosis: Tako-Tsubo cardiomyopathy","volume":"22","author":"Midaglia L","year":"2016","unstructured":"Midaglia L, Juega Mari\u00f1o JM, Sastre-Garriga J, et al.. An uncommon first manifestation of multiple sclerosis: Tako-Tsubo cardiomyopathy. Mult Scler. 2016, 22:842-6. 10.1177\/1352458516638557","journal-title":"Mult Scler"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo CA","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al.. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981, 30:239-45. 10.1038\/clpt.1981.154","journal-title":"Clin Pharmacol Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/79967-dimethyl-fumarate-induced-takotsubo-cardiomyopathy-in-a-patient-with-relapsing-remitting-multiple-sclerosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:44:19Z","timestamp":1707507859000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/79967-dimethyl-fumarate-induced-takotsubo-cardiomyopathy-in-a-patient-with-relapsing-remitting-multiple-sclerosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,3]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.23789","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,3]]}}}